SFRS11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.681800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.002000E-01
Normal-vs-Stage2
3.739200E-01
Normal-vs-Stage3
2.571200E-01
Normal-vs-Stage4
3.651800E-01
Stage1-vs-Stage2
8.096600E-01
Stage1-vs-Stage3
1.890560E-01
Stage1-vs-Stage4
6.664200E-01
Stage2-vs-Stage3
1.283810E-01
Stage2-vs-Stage4
4.256000E-01
Stage3-vs-Stage4
8.068300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.689400E-01
Normal-vs-AfricanAmerican
2.564600E-01
Normal-vs-Asian
3.536800E-01
Caucasian-vs-AfricanAmerican
6.676200E-01
Caucasian-vs-Asian
7.263200E-01
AfricanAmerican-vs-Asian
6.346800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.540400E-01
Normal-vs-Female
3.884000E-01
Male-vs-Female
2.630600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.125000E-01
Normal-vs-Age(41-60Yrs)
4.279400E-01
Normal-vs-Age(61-80Yrs)
3.497000E-01
Normal-vs-Age(81-100Yrs)
3.076400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.430800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.144200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.664400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.544500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.314000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.053200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.542600E-01
Normal-vs-Daily Drinker
3.190800E-01
Normal-vs-Weekly Drinker
3.355000E-01
Normal-vs-Occasional Drinker
4.132200E-01
Normal-vs-Social Drinker
4.214200E-01
Non Drinker-vs-Daily Drinker
4.714000E-01
Non Drinker-vs-Weekly Drinker
7.078400E-01
Non Drinker-vs-Occasional Drinker
3.566200E-01
Non Drinker-vs-Social Drinker
2.927400E-01
Daily Drinker-vs-Weekly Drinker
7.923400E-01
Daily Drinker-vs-Occasional Drinker
1.731210E-01
Daily Drinker-vs-Social Drinker
1.436580E-01
Weekly Drinker-vs-Occasional Drinker
2.851200E-01
Weekly Drinker-vs-Social Drinker
2.188200E-01
Occasional Drinker-vs-Social Drinker
9.129800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.594790E-01
Normal-vs-Grade 2
7.682300E-03
Normal-vs-Grade 3
2.736100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.790200E-01
Grade 1-vs-Grade 3
2.007600E-01
Grade 1-vs-Grade 4
1.594790E-01
Grade 2-vs-Grade 3
6.757600E-01
Grade 2-vs-Grade 4
7.682300E-03
Grade 3-vs-Grade 4
2.736100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.208000E-01
Normal-vs-NonDiabetic
3.630800E-01
Diabetic-vs-NonDiabetic
1.822600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.927000E-01
Normal-vs-NoPancreatitis
3.469600E-01
Pancreatitis-vs-NoPancreatitis
4.986400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.790600E-01
Normal-vs-N1
3.670800E-01
N0-vs-N1
7.888000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.044200E-01
Normal-vs-TP53-NonMutant
3.935400E-01
TP53-Mutant-vs-TP53-NonMutant
8.175800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
